Using virtual reality (VR) to explain what to expect ahead of a medical procedure could help patients better understand their treatment and reduce anxiety, a new study suggests. The research was ...

Using virtual reality (VR) to explain what to expect ahead of a medical procedure could help patients better understand their treatment and reduce ...

CDSCO warned that any form of advertisement -- direct or indirect -- promoting such medicines to the general public could ...

The Central Drugs Standard Control Organization (CDSCO) has issued an advisory cautioning pharmaceutical companies against direct or indirect promotional activities related to ...

India's CDSCO has warned pharma firms against promoting prescription weight-loss drugs (GLP-1s) via surrogate or digital ads, ...

The Centre has warned pharmaceutical companies against promoting prescription weight-loss GLP-1 drugs - popularly sold under brand names Oz.

The Drugs Controller General of India (DCGI) has issued strict warning against any surrogate advertisements, including awareness campaigns, for presc ...

Here's what you need to know about the potential side effects of weight loss medications ...

The Drugs Controller General of India (DCGI) has issued strict warning against any surrogate advertisements, including awareness campaigns, for presc ...

Those using weight loss injections may be susceptible to a number of side effects that occur in approximately "one in 10" people. Experts have flagged these issues as being "very common" amongst ...

A BLOOD pressure medication has been pulled from shelves over a potential packaging error. The “precautionary” measure was taken after a patient discovered another medicine in the ...

India’s CDSCO warns pharma companies against promoting prescription weight-loss drugs like Semaglutide and Liraglutide to the public, urging ethical marketing and holistic obesity care.